Sigma Healthcare poaches Total Tools boss

Sigma Healthcare has poached an experienced executive to be its new chief financial officer.

| More on:
A senior pharmacist talks to a customer at the counter in a shop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Sigma Healthcare has appointed a new chief financial officer. 
  • The new hire has decades of experience, including at a high level with JB Hi-Fi. 
  • The company's shares traded higher on the news.

Chemist Warehouse owner Sigma Healthcare Limited (ASX: SIG) has poached the boss of Total Tools to be its new chief financial officer.

The $34.6 billion company, created in February from the merger of the ASX-listed Sigma and the privately held Chemist Warehouse Group, said on Tuesday that Total Tools' Richard Murray would join on October 13.

Richard has extensive ASX listed company experience spanning over 30 years. Most recently, he was the Chief Executive Officer of Total Tools, a Division of Metcash Limited. Previously, Richard was with Premier Investments Ltd where he was CEO Premier Retail, overseeing The Just Group's seven retail brands with around 1100 stores globally.

Prior to his time at Premier, Mr Murray held senior leadership positions with JB Hi-Fi Limited (ASX: JBH) for almost 20 years, Sigma said, joining ahead of that company's listing on the ASX and overseeing its ascension to be an S&P/ASX 100 Index (ASX: XTO) company.

Most notably, Richard was Chief Financial Officer for twelve years and Chief Executive Officer for seven years. During this period, Richard drove strong store and revenue growth, focused on cost management and financial reporting, and the acquisition and subsequent integration of The Good Guys business.

Sigma shares traded as high as $3.05 on the news of Mr Murray's appointment before moderating to be changing hands for $3.02, up 2.4 cents.

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Premier Investments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A red heart-shaped balloon floats up above the plain white ones, indicating the best shares.
Healthcare Shares

Heart tech firm's shares surge after huge capital raise

A strategic investor has also jumped on board.

Read more »

Lab technician in lab with a tray of specimens
Healthcare Shares

Has this ASX 200 stock just turned the corner after 7% surge?

Brokers think the volatile biotech share can sustain the rally this time.

Read more »

Green stock market graph with a rising arrow symbolising a rising share price.
Opinions

3 ASX shares tipped to climb over 100% in 2026

Analysts expect steep gains this year.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Opinions

4DMedical shares crash 20% this week: Should investors cut their losses on the once-booming stock?

The shares are now down 6.61% for the year to date.

Read more »

A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
Healthcare Shares

Top broker tips 57% upside for beaten-down Telix shares

A leading broker expects a big rebound in Telix shares in 2026.

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

Here's why Anteris shares are in a trading halt today

The company is undertaking a US$300m capital raising.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Telix shares in focus as the company meets guidance

More good news from the drug developer.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

What are the healthcare stocks where RBC Capital Markets thinks you can make money?

The top buys in the sector, listed.

Read more »